CONCLUSIONS: The safety of treatment with @entity2419 remains high 3 years after the procedure. The implant extrusion rate decreases over time. Additional surgery to the palate is safe. The presence of the implants seems important in sustaining efficacy past 1 year. OBJECTIVES: To investigate long-term safety and treatment results of @entity2419 for treatment of snoring. METHODS: A prospective clinical non-randomized trial of 55 @entity1 with primary snoring followed over a period of 3 years. RESULTS: No major adverse events were observed. Eleven of the 55 @entity1 (20%) experienced implant extrusions, 8 during the first year, 3 in the second, and none in the third year. Twenty-six @entity1 (47.3%) had additional procedures past 1 year. Only one post-implant surgery caused an extrusion. The success defined as no additional surgery followed by endpoint satisfaction rate was 34.6%. For @entity1 with implants intact it was 41.5% (17/41) at 3 years, significantly better than for those who experienced loss of implants.

Three-year follow-up of XXXX for the treatment of snoring.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2419 :: ('MESH:D002972', 'Disease') :: ['palatal implants']
@entity2419 :: (MESH:D002972,Disease) :: ['palatal implants']
